Loading clinical trials...
Loading clinical trials...
A Double-Blinded, Placebo-Controlled, Randomized, Phase 1/2a Clinical Study to Test the Safety and Efficacy of a Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Conditions
Interventions
Clemastine Fumarate Combined With Engineered Sound
Clemastine Fumarate Combined With Pink Noise
+2 more
Locations
1
United States
University of Colorado Anschutz Medical Center
Aurora, Colorado, United States
Start Date
December 15, 2025
Primary Completion Date
July 1, 2028
Completion Date
July 1, 2028
Last Updated
December 26, 2025
NCT04915183
NCT05572073
NCT07416292
NCT05668338
NCT07402941
NCT06058767
Lead Sponsor
University of Colorado, Denver
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions